While the impact of common genetic variants on transcript abundance in response to cellular stimuli has been analyzed in depth, less is known about how stimulation modulates the genetic control of isoform usage. Using RNA-seq profiles of monocyte-derived dendritic cells from 243 individuals, we uncovered thousands of unannotated isoforms synthesized in response to viral infection or stimulation with Type 1 interferon. We identified more than a thousand single nucleotide polymorphisms associated with isoform usage (isoQTLs), many of which are independent of expression QTLs for the same gene. Compared to eQTLs, isoQTLs are enriched for splice sites and untranslated regions, and depleted of upstream sequences. In five loci, they provide a possible mechanism of action underlying DNA variants associated with immune-related disorders. Among these five is the ERAP2 locus, where the major haplotype is under balancing selection and associated with Crohn's disease risk. At baseline and following Type 1 interferon stimulation, the major haplotype is associated with absence of ERAP2 expression; but in response to influenza infection, the major haplotype results in the expression of two previously uncharacterized, alternatively transcribed, spliced and translated short isoforms. Thus, genetic variants at a single locus could modulate independent gene regulatory processes in the innate immune response, and in the case of ERAP2, may confer a historical fitness advantage in response to virus, but increase risk for autoimmunity in the modern environment.
Introduction
An important aspect of eukaryotic gene regulation is the control of alternative gene isoforms. This is achieved through several mechanisms at the transcript level, including: alternative promoters for transcription initiation, alternative splicing of pre-messenger RNA, alternative polyadenylation, and selective degradation of isoforms. These processes regulate the relative abundances of multiple coding and non-coding RNAs from the same underlying DNA sequence, often resulting in altered function of the protein products in response to developmental or environmental changes [1] [2] [3] [4] .
A case in point is the role of alternative isoform usage in the human immune response. For example, studies have shown that alternative splicing is critical across many immune processes, such as B cell functions reflected in the balance between IgM and IgD immunoglobulin isoforms 5 , naïve and memory T cell functions controlled by CD45 isoforms 6 , and innate immune responses to pathogens regulated by different isoforms of MYD88 7 . Genetic variants that affect isoform usage have been associated with immune disorders 8 including the association of systemic lupus erythematosus (SLE) with common variants in a splice site at the IRF5 locus 9 .
Previous studies have identified shared and divergent transcriptional programs in the antibacterial and antiviral response of innate immune cells 10, 11 , with genetic variation imparting stimulation specific effects on gene expression [11] [12] [13] [14] . While genetic maps of alternative splicing are beginning to emerge, most notably in lymphoblastoid cell lines 15, 16 , across healthy human tissues 17, 18 , and in macrophages stimulated with bacteria 19 , variability in isoform usage across individuals and its genetic basis in the human antiviral response have not been studied.
Here, we integrate RNA-sequencing with dense genotyping to systematically investigate the genetic control of isoform usage in monocyte derived dendritic cells (MoDCs) at rest, and in response to influenza-infection or Type 1 interferon. Because the Type 1 interferon pathway is known to be engaged by a broad array of microbial products, our study design is unique in allowing the separation of the universal and influenza-specific effects on the interferon-induced response. Since the human transcriptome has never been annotated under these conditions, we first used de novo assembly to catalog and quantify all synthesized isoforms in resting and stimulated cells. Then, by harnessing the natural transcriptomic and genetic variation in the ImmVar cohort 11, 20, 21 , we mapped genetic variants (isoQTLs) associated with isoform usage. Systematic characterization of isoQTLs, especially in comparison to eQTLs, provides mechanistic insights into the genetic control of different aspects of gene regulation and enables the functional interpretation of loci associated with immune disease and under natural selection.
Results

Influenza and Type I interferon stimulate widespread alternate isoform usage
We used paired-end RNA-seq to profile the transcriptomes of primary monocyte-derived dendritic cells (MoDCs) from healthy donors at rest (N = 99), and following stimulation with either influenza ΔNS1 (a strain engineered to maximize the IFNβ-induced host response to infection by the deletion of a key virulence factor 22 ) (N = 250) or interferon beta (IFNβ), a cytokine that stimulates anti-viral effectors (N = 227). A total of 552 pass-filter samples (out of 576), 84 from all three conditions, 127 from both stimulation conditions, and 46 from only one condition, were analyzed (Table S1 ). To define the corpus of transcripts in human dendritic cells at rest and in response to stimulation, including previously unannotated transcripts, we assembled the transcriptome de novo in each sample (individual-condition pair), retained only expressed isoforms (> 5 transcripts per million in any sample), then combined isoforms across all samples to enable direct comparisons between conditions. Overall, we identified 35,411 transcripts: 18,644 present in resting cells, and 29,841 (flu) and 25,127 (IFNβ) present in stimulated cells. The 35,411 transcripts correspond to 15,123 genes, including 8,338 previously unannotated transcription start sites (TSSs) (corresponding to 5,414 genes), 16,062 previously unannotated splice sites (corresponding to 11,704 isoforms and 6,703 genes), and 1,653 previously unannotated transcripts (corresponding to 1,281 genes) ( Table S2 ).
Compared to IFNβ induction, flu infection elicited a prominent change in isoform usage independent of gene expression, estimated as the ratio of isoform abundance over total gene abundance. Relative to baseline, the usage of 3x as many isoforms (4,937 vs 1,651) were altered in flu-infected compared to IFNβ-stimulated cells (beta regression, FDR < 0.01, isoform abs(log 2 (fold change)) > 1, Table S3 , Fig.   S1 ). In response to both conditions, more than 50% of isoforms with differential usage were previously unannotated, highlighting the inadequacy of current annotations in describing the full diversity of gene isoforms in the human antiviral response. Of the differentially expressed genes with more than one isoform, 36% (flu, 1326/3680) and 22% (IFNβ, 433/1995) had at least one isoform that differed in usage ( Fig. 1A) , suggesting independent regulatory mechanisms that control overall gene abundance and specific isoform usage in response to stimuli.
Isoforms that differed in usage partitioned into five prominent clusters ( Fig. 1B , k-means clustering).
Isoforms with decreased usage in response to both stimuli (cluster IV) were enriched for mitochondria function (GO:0044429, P < 2.1×10 -7 , Table S4 ) while those in response to one stimulus were either enriched for broad biological function (flu, cluster V, Table S4 ) or not enriched for known gene ontology entries (IFNβ, cluster III). Isoforms with increased usage in response to influenza were either shared with (cluster II) or independent of IFNβ stimulation (cluster I). Isoforms upregulated in response to flu (cluster I and II) were enriched for known influenza responsive genes (KEGG: Influenza A, P < 4.2×10 -4 and P < 7.6×10 -2 , Table S5 ) while isoforms specific to flu-infection were also enriched for viral sensing genes including the Toll-like receptor (TLR) pathway (KEGG: Toll Like Receptor Signaling Pathway, P < 3.9×10 -4 , Table S5 ). Among the genes within the flu-specific cluster was TLR4 (Fig. 1C) , the toll-like receptor classically associated with sensing bacterial ligands but have been shown to also sense viral products 23 . In flu-infected cells, the usage of longer isoforms with an upstream alternative start site (TLR4/Iso1 and TLR4/Iso2) was decreased, while the usage of TLR4/Iso3, TLR4/Iso4, and TLR4/Iso7 was increased. Although TLR4/Iso4 encodes the annotated 839 amino acid (aa) product, isoforms TLR4/Iso3 and TLR4/Iso7 encode shorter, 799 aa products each with a truncated extracellular domain missing a predicted signal peptide. Additionally, we also found flu-specific isoform control of CASP8 (Fig. 1D) ,
where usage of short isoforms (CASP8/Iso4, CASP8/Iso5, CASP8/Iso6) was decreased only in fluinfected cells. Although CASP8 is known to induce the apoptotic program via Fas-associated death domain (FADD) protein in response to extrinsic cytokine signals, CASP8/Iso4 has a unique N-terminal extension of 59 amino acids, which has been reported to allow for selective recruitment to the endoplasmic reticulum 24 . These results demonstrate that changes in isoform usage independent of overall gene abundance are pervasive and affect prominent innate immune sensors and regulators in viral versus interferon response.
Genetic determinants of isoform usage are associated with distinct regulatory features compared to those of gene expression
We assessed whether common genetic variants, known to affect gene expression 11 , could affect isoform usage in both resting and stimulated MoDCs. We associated over 10M imputed variants with two transcriptional traits, isoform percentage and total gene abundance, to identify isoform usage quantitative trait loci (isoQTLs) and expression quantitative trait loci (eQTLs), respectively. After adjusting for unwanted variation from latent effects ( Fig. S2 and S3) , we identified 2,393 isoforms corresponding to 1,345 genes (linear regression, permutation FDR < 0.05, Table S6 ) with local isoQTLs (+/-500kb of TSS) and 8,350 genes (linear regression, permutation FDR < 0.05, Table S7 ) with local eQTLs in at least one condition. A substantial proportion of leading isoQTL SNPs (58% baseline, 42% flu, 39% IFNβ) were not significant eQTLs, suggesting that the genetic control of isoform usage and overall gene abundance are largely independent.
Genetic variants could modulate isoform usage through several mechanisms including perturbing the usage of alternate promoters, splice sites, or regulatory elements in the untranslated regions (UTRs). We compared the cis properties of isoQTLs and eQTLs to identify the mechanisms by which each class of variants acts. When normalized by exon and intron lengths, leading SNPs for local isoQTLs were enriched across the entire gene body ( Fig. 2A) , in distinct contrast with leading SNPs for local eQTLs, which were enriched near TSS and transcription end site (TES). Further, when compared to a set of SNPs matched for allele frequency and distance to TSS, leading SNPs for local isoQTLs were most enriched for splice sites (4.8x baseline, 2.8x flu, 2.7x IFNβ), synonymous (1.6x baseline, 1.6x flu, 2.1x IFNβ) and missense variants (2.0x baseline, 1.4x flu, 1.9x IFNβ), and 5' (1.7x baseline, 1.1x flu, 1.4x IFNβ) and 3'
(1.5x flu, 1.4x IFNβ) UTRs (Fig. 2B) . Compared to eQTLs, isoQTLs are not enriched for binding sites of transcription factors known to play a role in myeloid cell response (Fig. S4) . These results suggest that genetic variants associated with isoform usage likely do so via cis regulatory sequences that modulate alternative splicing and transcript stability.
Because alternate isoforms could result in protein products of drastically different function that may affect the expression of other genes, we next assessed the trans regulatory properties of isoQTLs. Testing only significant local eQTLs and isoQTLs for possible trans associations resulted in higher multiple testing power to detect distal QTLs, with the strongest signal observed in flu-infected cells (Fig. 2C, Table S8 ).
In stimulated cells, the expressions of 95 (flu) and 55 (IFNβ) genes were distally associated (> 1M base pairs) with isoQTLs (linear regression, permutation FDR < 0.1) (Table S8) , in contrast to 492 and 49 genes distally associated with eQTLs (linear regression, permutation FDR < 0.1). Leveraging the distribution of permuted P-values, we estimated that 20% (flu) and 16% (IFNβ) of genes are associated in trans with isoQTLs and 41% (flu) and 39% (IFNβ) of genes are associated in trans with eQTLs. These results suggest that local eQTLs are more likely to affect trans gene expression than local isoQTLs and that both local eQTLs and isoQTLs are more likely to affect trans gene expression in influenza-infected than IFNβ-stimulated cells.
Genetic control of alternative isoform usage in responses to virus and interferon
To assess how the genetic control of isoform usage differs in response to stimuli, we analyzed 84 donors whose cells were assayed in all three conditions to enable equally powered comparisons across conditions. Genetic variants imparted stronger effects on isoform usage in resting and IFNβ-infected cells than in flu-infected cells as indicated by more isoQTLs detected (815 in resting, 784 in IFNβ and 427 in flu, permutation FDR < 0.05) and an increase in the proportion of variance of isoform usage explained (R iso 2 ) by the associated variants (Fig. 3A) . The correlation of R iso 2 was lowest between flu-infected and resting (baseline) cells (Pearson ⍴ flu.baseline =0.46 compared to ⍴ IFN.baseline =0.69 and ⍴ IFN.flu =0.66) suggesting flu-specific genetic control of isoform usage independent of Type 1 interferon signaling. Isoforms with higher R iso 2 in stimulated cells are upregulated in response to stimuli, suggesting that the activation of specific gene regulatory programs that control isoform usage are sensitive to genetic effects unobserved in inactive states (Fig. 3B) .
To directly assess how stimulation modifies the effects of individual genetic variants on isoform usage, we mapped SNPs associated with the difference in isoform usage between conditions, herein referred to as local response-isoQTLs (risoQTLs). Compared to resting cells, we identified 74 (flu) and 22 (IFNβ) significant local risoQTLs corresponding to 50 and 14 genes (permutation FDR < 0.1, Table S9 ).
Amongst the 13 genes that share local risoQTLs in both stimulated conditions were IFI44L and WARS (Fig. 3C) , two genes whose splicing has previously been studied. IFI44L is a type 1 interferon-stimulated gene that has been shown to have moderate effects in inhibiting human hepatitis virus replication in vitro 25 and whose splicing has been shown to be influenced by the most significant risoQTL (rs1333973) 26 . Although WARS, a tryptophanyl-tRNA synthesase, is primary involved in protein synthesis with other family members known to encode for catalytic null enzymes 27 , it also has a known spliced form induced by IFNγ that has anti-angiogenic activity 28 . Among the 37 genes that have risoQTLs in fluinfected but not interferon-stimulated cells was ZBP1, a sensor of influenza infection that triggers cell death and inflammation and contributes to virus-induced lethality 29 signaling.
Association of eQTLs and isoQTLs with immune-related diseases
Previous analyses of the overlap between expression QTLs and genome-wide association studies (GWAS) have aided the localization and functional interpretation of causal variants in GWAS loci.
Because disease-causing variants that modulate isoform usage could have more profound effects on gene regulatory networks by altering protein structure, we compared leading local isoQTL and local eQTL SNPs with the latest GWAS catalog 30 . While local eQTLs in stimulated cells were enriched in multiple diseases including inflammatory bowel disease (flu P < 5.46×10 -7 , IFNβ P < 5.21×10 -5 ), rheumatoid arthritis (flu P < 2.49×10 -5 , IFNβ P < 0.03), and Parkinson's disease (flu P < 4.06×10 -7 , IFNβ P < 7.44×10 -5 ) (Fig. 4A) , local isoQTLs were enriched in late onset Alzheimer's disease (flu P < 1.15×10 -6 , IFNβ P < 1.75×10 -4 ), vitiligo (flu P < 4.94×10 -5 , IFNβ P < 0.42), and systemic lupus erythmatosus (SLE) (flu P < 0.1, IFNβ P < 3.62×10 -3 ) (Fig. 4B) . Notably, the significant overlap with Alzheimer's loci is only found for isoQTLs and not for eQTLs (flu P < 0.9, IFNβ P < 1) due to the overlap of genes with known splicing variants (CD33 31,32 , CD46 33 ) and genes with unvalidated isoQTLs controlling transcript usage (CR1L). These results suggest a role for both variants that affect isoform usage and gene expression in mediating autoimmune and neurodegenerative disease risk.
One of the disease-associated isoQTLs lies in the IRF7 locus within an extended haplotype known to be associated with SLE (rs58688157 lead SNP, P < 2.97×10 -11 ) 34 (Fig. 4B) . A linked SNP (rs1061502; LD R 2 = 0.93, D' = 0.97 to rs58688157) is the most significant association to overall IRF7 expression in IFNβstimulated (P < 2.87×10 -49 ) and flu-infected cells (P < 2.21×10 -25 ) (Fig. 4C, Fig. S5 ). IsoQTL analysis further revealed that rs1061502 T also increased the usage of IRF7/Iso4 (flu beta = 5.3%, P < 9.42×10 -52 , IFNβ beta = 5.8%, P < 4.81×10 -46 , Fig. 4C, panel 3 , purple) while decreasing the usage of IRF7/Iso3 (flu beta = -3.4%, 1.15×10 -15 , IFNβ beta = -7.0%, 2.04×10 -29 , Fig. 4C, panel 3 , green). Further, although the overall IRF7 abundance was similar between the two stimulated conditions, IRF7/Iso4 (purple) was the dominant isoform in flu-infected cells, but not IFNβ-stimulated cells (10.7x fold, P < 10 -306 ) (Fig. 4C, bottom panel). rs1061502 was also a distal eQTL (permutation FDR < 0.2) for a cluster of genes including NMI, type-1 interferon IFNA2, IFIT5, and C5 only in flu-infected, but not in IFNβ-stimulated cells (Fig. 4D) . These results replicate and expand our previous findings that rs12805435 (LD R 2 = 0.95, D' = 0.98 to rs1061502) is associated in cis with IRF7 expression in these two conditions, and in trans with a cluster of IRF7-regulated genes only in flu-infected cells 11 
An ERAP2 risoQTL controls differential transcript usage during influenza infection
The ERAP2 locus is characterized by two frequent and highly differentiated (40 SNPs in perfect LD) haplotypes observed in every major human population (B: 53% and A: 47%) (Fig. S6) . The major allele (G) of rs2248374, a splice-site variant tagging Haplotype B, creates an alternate 3' donor splice site inducing the splicing of an extended exon 10 with two premature termination codons 35 . As a result, transcripts from Haplotype B are degraded by nonsense-mediated decay resulting in one of the most significant eQTLs and isoQTLs in most tissues and cell types 11, 15, 17, 21 . Intriguingly, while Haplotype B is associated with increased risk for Crohn's disease 36 (Fig. 5A) , it is also maintained by long term balancing selection (between 1.4M 35 Given the known role of ERAP2 in antigen presentation 38 , we examined the genetic control of ERAP2 transcripts in the human antiviral response. In resting and IFNβ-stimulated cells, we confirmed the known genetic association of rs2248374 G allele with lower ERAP2 expression ( Fig. 5B) . Remarkably, while the overall abundance of ERAP2 was elevated in stimulated conditions, two previously uncharacterized short isoforms (ERAP2/Iso2, ERAP2/Iso3, Fig. 5B, Fig. S7 ) were transcribed from Haplotype B only in fluinfected and not IFNβ-stimulated cells, resulting in the partial rescue of ERAP2 expression. The short isoforms differed from the constitutive full-length isoform (ERAP2/Iso1 transcribed from Haplotype A) by the initiation of transcription at exon 9 and the alternate splicing of an extended exon 10, and differed from each other by alternative splicing at a secondary splice site at exon 15. The initiation of transcription at exon 9 results in an alternate in-frame translation start site at exon 11 thus rendering the premature termination codon in exon 10 inactive. The influenza-dependent genetic control of ERAP2 isoform usage is further supported by (i) correlation between overall flu transcript abundance, a proxy for degree of infection, and ERAP2/Iso2 (R 2 = 0.57) and ERAP2/Iso3 (R 2 = 0.7) ( Fig. 5C triangles) , (ii) evidence of alternative translation starting at exon 11 as shown by the detection of flu-specific protein isoforms (50 kDa) in flu-infected cells from Haplotype B homozygotes and heterozygotes (Fig. 5D) , and (iii) evidence of transcription of ERAP2/Iso2 or ERAP2/Iso3 (marked by an extended exon 10) in monocyte derived macrophages infected by H3N2 over a time course (fluomics, GEO GSE97672) (Fig. 5E) .
The complex genetic signals at the ERAP2 locus is consistent with three perfectly linked variants on Haplotype B affecting ERAP2 transcription and splicing in response to viral stimulation independent of Type 1 interferon signaling (Fig. 5F) . Rs2548538, an intronic variant that overlaps chromatin marks from LCLs 39 , likely causes alternate transcript initiation at exon 9. Rs2248374 G , the known splice site mutation, creates an alternate preferred splice site resulting in alternative splicing of an extended exon 10.
Rs2549797 G , a splice-site mutation that creates a competing alternate splice site, results in ~40% of the transcripts with an extended exon 15. The signature of natural selection, the previous disease associations, and the viral specific transcription suggest a critical antiviral role for the short ERAP2 isoforms that could also result in an overactive autoinflammatory response in Crohn's disease.
Discussion
Although maps of genetic variants associated with overall transcript abundance have been generated in many tissue types, the genetic control of alternate isoform usage has not been extensively studied. Using de novo transcript reconstruction, we found a large number of previously uncharacterized transcripts in human dendritic cells, especially in response to influenza and interferon stimulation, indicating that the current reference human transcriptome is far from complete. We further found genetic variants (isoQTLs) associated with alternate isoform usage are widespread, approximately half of which are not associated with the overall abundance of the corresponding gene, indicative of independent genetic control of gene regulation at most loci of the genome. The enrichment of isoQTLs for known splice sites and disease loci suggest a highly clinically relevant set of candidate loci that would induce targetable changes in protein sequence.
IsoQTLs, like eQTLs, can affect gene expression at other loci in the genome suggesting important downstream effects on gene regulation. The most striking example is at the IRF7 locus where a splice-site SNP affects IRF7 splicing in response to influenza and interferon, but only affects the expression of downstream genes in response to flu. This suggests that both genetic effects on isoform usage and stimulation dependent regulation of IRF7 expression are necessary for the observed trans effects.
Although C-terminal splice forms of IRF7 have been shown to differentially transactivate type-1 interferons and chemokines 40 , IRF7/Iso4 is not known to have specific antiviral properties in vivo even though its ectopic expression is known to activate IFNAs in fibroblasts 41 . The association of the variant with SLE indicates a possible role for viral exposure to prime the immune system of individuals carrying the risk allele toward autoimmunity.
Different genetic variants in a locus could also affect multiple facets of gene regulation in response to stimulation in establishing transcriptome diversity and susceptibility to disease. This was clearly demonstrated at the ERAP2 locus where multiple variants on the Crohn's disease-associated haplotype lead to differential expression and splicing of the transcript in response to influenza. Previous experimental evidence has shown that full length ERAP2 is a prototypical aminopeptidase that heterodimerizes with ERAP1 38 to perform peptide trimming during MHC class I presentation. The lack of the aminopeptidase domain in the flu-specific ERAP2 isoforms suggests that it could interact with ERAP1
to negatively influence antigen presentation or adopt previously unknown immunological function.
Altogether, this dataset can help elucidate the mechanisms underlying disease alleles by providing deeper molecular data for each gene in baseline and inflammation. 
